-
For CF, FDA Approves Trikafta with Potential to Treat 90% of Patients
The U.S. FDA has approved Vertex’s triple combo therapy Trikafta, which has the potential to treat 90% of all cystic fibrosis patients. Click here to read more about this new treatment.
These are very exciting news! Is there anyone out there for whom this is a FIRST CF treatment? How does it feel to finally have a Vertex combo therapy that treats you? Can we ask what disease-causing mutations you have?
-
0 Replies
Sorry, there were no replies found.
Log in to reply.